Patents by Inventor Soren Erik Bjorn

Soren Erik Bjorn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Derivatives of GLP-1 analogs
    Patent number: 8097698
    Abstract: The present invention relates to a pharmaceutical composition comprising a GLP-1 derivative having a lipophilic substituent; and a surfactant.
    Type: Grant
    Filed: November 26, 2007
    Date of Patent: January 17, 2012
    Assignee: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Per Olaf Huusfeldt, Per Franklin Nielsen, Niels C. Kaarsholm, Helle Birk Olsen, Soren Erik Bjorn, Freddy Zimmerdahl Pedersen, Kjeld Madsen
  • Derivatives Of GLP-1 Analogs
    Publication number: 20090176700
    Abstract: The present invention relates to a pharmaceutical composition comprising a GLP-1 derivative having a lipophilic substituent; and a surfactant.
    Type: Application
    Filed: November 26, 2007
    Publication date: July 9, 2009
    Applicant: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Per Olaf Huusfeldt, Per Franklin Nielsen, Niels C. Kaarsholm, Helle Birk Olsen, Soren Erik Bjorn, Freddy Zimmerdahl Pedersen, Kjeld Madsen
  • Human Spasmolytic Polypeptide in Glycosylated Form
    Publication number: 20090011461
    Abstract: Human spasmolytic polypeptide (HSP) which has the amino acid sequence Glu Lys Pro Ser Pro Cys Gln Cys Ser Arg Leu Ser Pro His Asn Arg Thr Asn Cys Gly Phe Pro Gly Ile Thr Ser Asp Gln Cys Phe Asp Asn Gly Cys Cys Phe Asp Ser Ser Val Thr Gly Val Pro Trp Cys Phe His Pro Leu Pro Lys Gln Glu Ser Asp Gln Cys Val Met Glu Val Ser Asp Arg Arg Asn Cys Gly Tyr Pro Gly Ile Ser Pro Glu Glu Cys Ala Ser Arg Lys Cys Cys Phe Ser Asn Phe Ile Phe Glu Val Pro Trp Cys Phe Phe Pro Asn Ser Val Glu Asp Cys His Tyr or a functionally equivalent homologue thereof, characterized by being in glycosylated form.
    Type: Application
    Filed: February 29, 2008
    Publication date: January 8, 2009
    Applicant: Novo Nordisk A/S
    Inventors: Lars Thim, Kjeld Norris, Fanny Norris, Soren Erik Bjorn, Mogens Christensen, Per Franklin Nielsen
  • Human Spasmolytic Polypeptide in Glycosylated Form
    Publication number: 20080274964
    Abstract: Human spasmolytic polypeptide (HSP) which has the amino acid sequence Glu Lys Pro Ser Pro Cys Gln Cys Ser Arg Leu Ser Pro His Asn Arg Thr Asn Cys Gly Phe Pro Gly Ile Thr Ser Asp Gln Cys Phe Asp Asn Gly Cys Cys Phe Asp Ser Ser Val Thr Gly Val Pro Trp Cys Phe His Pro Leu Pro Lys Gln Glu Ser Asp Gln Cys Val Met Glu Val Ser Asp Arg Arg Asn Cys Gly Tyr Pro Gly Ile Ser Pro Glu Glu Cys Ala Ser Arg Lys Cys Cys Phe Ser Asn Phe Ile Phe Glu Val Pro Trp Cys Phe Phe Pro Asn Ser Val Glu Asp Cys His Tyr or a functionally equivalent homologue thereof, characterized by being in glycosylated form.
    Type: Application
    Filed: February 29, 2008
    Publication date: November 6, 2008
    Applicant: NOVO NORDISK A/S
    Inventors: Lars Thim, Kjeld Norris, Fanny Norris, Soren Erik Bjorn, Mogens Christensen, Per Franklin Nielsen
  • GLP-2 derivatives
    Publication number: 20040127418
    Abstract: Analogs of GLP-2, pharmaceutical compositions comprising GLP-2 analogs, and methods of treating diseases and disorders comprising administering such analogs or compositions are provided.
    Type: Application
    Filed: December 8, 2003
    Publication date: July 1, 2004
    Inventors: Liselotte Bjerre Knudsen, Per Olaf Huusfeldt, Per Franklin Nielsen, Niels C. Kaarsholm, Helle Birk Olsen, Lars Thim, Soren Erik Bjorn
  • Derivatives of GLP-1 analogs
    Publication number: 20030199672
    Abstract: The present invention relates to a pharmaceutical composition comprising a GLP-1 derivative having a lipophilic substituent; and a surfactant.
    Type: Application
    Filed: August 19, 2002
    Publication date: October 23, 2003
    Inventors: Liselotte Bjerre Knudsen, Per Olaf Huusfeldt, Per Franklin Nielsen, Niels C. Kaarsholm, Helle Birk Olsen, Soren Erik Bjorn, Freddy Zimmerdahl Pedersen, Kjeld Madsen
  • GLP-2 derivatives
    Publication number: 20020025933
    Abstract: The present invention relates to derivatives of hGLP-2 and analogues and/or fragments thereof having a lipophilic substituent have interesting pharmacological properties, in particular they have a more protracted profile of action than the parent peptides.
    Type: Application
    Filed: July 18, 2001
    Publication date: February 28, 2002
    Inventors: Liselotte Bjerre Knudsen, Per Olaf Huusfeldt, Per Franklin Nielsen, Niels C. Kaarsholm, Helle Birk Olsen, Lars Thim, Soren Erik Bjorn
  • DERIVATIVES OF GLP-1 ANALOGS
    Publication number: 20010011071
    Abstract: The present invention relates to a pharmaceutical composition comprising a GLP-1 derivative having a lipophilic substituent; and a surfactant.
    Type: Application
    Filed: September 16, 1999
    Publication date: August 2, 2001
    Inventors: LISELOTTE BJERRE KNUDSEN, PER OLAF HUUSFELDT, PER FRANKLIN NIELSEN, NIELS C. KAARSHOLM, HELLE BIRK OLSEN, SOREN ERIK BJORN, FREDDY ZIMMERDAHL PEDERSEN, KJELD MADSEN
  • Derivatives of GLP-1 analogs
    Patent number: 6268343
    Abstract: The present invention relates to GLP-1 derivatives having a lipophilic substituent, pharmaceutical compositions comprising same, and methods of making an using same. The GLP-1 derivatives of the present invention have a protracted profile of action.
    Type: Grant
    Filed: February 26, 1999
    Date of Patent: July 31, 2001
    Assignee: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Per Olaf Huusfeldt, Per Franklin Nielsen, Niels C. Kaarsholm, Helle Birk Olsen, Søren Erik Bjørn, Freddy Zimmerdahl Pedersen, Kjeld Madsen